Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $24.24 million. The enterprise value is $21.63 million.

Market Cap	24.24M
Enterprise Value	21.63M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 28.79 million shares outstanding. The number of shares has increased by 12.58% in one year.

Current Share Class	28.79M
Shares Outstanding	28.79M
Shares Change (YoY)	+12.58%
Shares Change (QoQ)	+2.19%
Owned by Insiders (%)	28.24%
Owned by Institutions (%)	10.41%
Float	18.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	84.91
Forward PS	115.90
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	103.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-145.31%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	2,532.09%
Revenue Per Employee	$4,952
Profits Per Employee	-$681,214
Employee Count	42
Asset Turnover	0.02
Inventory Turnover	0.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.91% in the last 52 weeks. The beta is 2.07, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y)	2.07
52-Week Price Change	-59.91%
50-Day Moving Average	0.81
200-Day Moving Average	1.27
Relative Strength Index (RSI)	56.09
Average Volume (20 Days)	496,114

Short Selling Information

The latest short interest is 629,475, so 2.19% of the outstanding shares have been sold short.

Short Interest	629,475
Short Previous Month	588,581
Short % of Shares Out	2.19%
Short % of Float	3.47%
Short Ratio (days to cover)	1.27

Income Statement

In the last 12 months, Envoy Medical had revenue of $208,000 and -$28.61 million in losses. Loss per share was -$1.36.

Revenue	208,000
Gross Profit	-612,000
Operating Income	-20.43M
Pretax Income	-21.79M
Net Income	-28.61M
EBITDA	-20.16M
EBIT	-20.43M
Loss Per Share	-$1.36

Full Income Statement

Balance Sheet

The company has $3.56 million in cash and $946,000 in debt, giving a net cash position of $2.61 million or $0.09 per share.

Cash & Cash Equivalents	3.56M
Total Debt	946,000
Net Cash	2.61M
Net Cash Per Share	$0.09
Equity (Book Value)	-7.53M
Book Value Per Share	-0.32
Working Capital	-3.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.61 million and capital expenditures $527,000, giving a free cash flow of -$17.08 million.

Operating Cash Flow	-17.61M
Capital Expenditures	527,000
Free Cash Flow	-17.08M
FCF Per Share	-$0.59

Full Cash Flow Statement

Margins

Gross Margin	-294.23%
Operating Margin	-9,824.04%
Pretax Margin	-10,475.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.58%
Shareholder Yield	-12.58%
Earnings Yield	-118.05%
FCF Yield	-70.48%

Analyst Forecast

The average price target for Envoy Medical is $9.50, which is 1,028.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	1,028.40%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -59.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-59.7
Piotroski F-Score	2